Ikarian Capital, LLC Acadia Pharmaceuticals Inc Put Options Transaction History

Ikarian Capital, LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2021 May 17, 2021	BUY	$25.02 - $54.99 $12 Million - $26.3 Million	478,300 Added 478.3%	578,300 $14.9 Million
Q3 2020 Nov 16, 2020	SELL	$36.42 - $57.0 $3.64 Million - $5.7 Million	-100,000 Reduced 50.0%	100,000 $4.13 Million
Q2 2020 Aug 14, 2020	SELL	$39.26 - $52.73 $1.57 Million - $2.11 Million	-40,000 Reduced 16.67%	200,000 $9.69 Million
Q1 2020 May 15, 2020	BUY	$31.65 - $46.87 $3.17 Million - $4.69 Million	100,000 Added 71.43%	240,000 $10.1 Million
Q4 2019 Jan 31, 2020	BUY	$36.21 - $51.4 $5.07 Million - $7.2 Million	140,000 New	140,000 $5.99 Million

279

156M

901K

314K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.76B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ikarian Capital, LLC with notifications on news.